A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)

Clinical trial NCT06881251 · TERMINATED

Trial details

NCT number: NCT06881251
Sponsor: Janssen Research & Development, LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2025-02-26
Primary completion: 2026-03-26
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.